129 related articles for article (PubMed ID: 4389845)
21. Therapeutic observations with Tavegyl.
Pólay A
Ther Hung; 1980; 28(2):82-6. PubMed ID: 6110250
[No Abstract] [Full Text] [Related]
22. [Drug-induced changes in allergic mediatory reactivity in constitutional neurodermatitis patients].
Borelli S; Ene-Popescu C; Michailov P
Z Haut Geschlechtskr; 1969 Feb; 44(3):93-8. PubMed ID: 4391262
[No Abstract] [Full Text] [Related]
23. [Clinical study of a new antihistaminic agent, Tavist].
Gyde MC
Vie Med Can Fr; 1972 Feb; 1(2):151-5. PubMed ID: 4404676
[No Abstract] [Full Text] [Related]
24. [Experience with a new antihistaminic (Tavegyl, Sandoz) in a dermatologic-allergologic practice].
Wortmann F
Dermatol Wochenschr; 1968 Nov; 154(48):1129-33. PubMed ID: 4389418
[No Abstract] [Full Text] [Related]
25. [Tavegil in the dermatological practice].
Gehrels PE
Med Klin; 1968 Jun; 63(26):1043-5. PubMed ID: 4387352
[No Abstract] [Full Text] [Related]
26. A new antihistaminic drug (Tavegyl) in allergic diseases.
Hajós M
Ther Hung; 1971; 19(2):67-9. PubMed ID: 4152119
[No Abstract] [Full Text] [Related]
27. [Clinical evaluation of a new antihistaminic: HS-592].
von Bernath Z
Prensa Med Argent; 1971 Jul; 58(21):1071-5. PubMed ID: 4398545
[No Abstract] [Full Text] [Related]
28. [Experiences with Ehrtolan in general practice].
Dietz O
Z Allgemeinmed; 1970 Oct; 46(30):1511-5. PubMed ID: 4394481
[No Abstract] [Full Text] [Related]
29. [Daily dermatologic therapy].
Tchou PK
Laval Med; 1970 Sep; 41(7):951-4. PubMed ID: 4396423
[No Abstract] [Full Text] [Related]
30. [Clinical evaluation of the antihistaminic activity of a new antihistaminic product with selective and non hypnotic action (HS 592)].
De Caro L; Rizzo SC
Folia Allergol (Roma); 1969; 16(3):234-48. PubMed ID: 4397213
[No Abstract] [Full Text] [Related]
31. [Experience with an oral corticoid-antihistaminic combination in dermatological practice].
Foelsche W
Berufsdermatosen; 1968 Jun; 16(3):164-9. PubMed ID: 4386154
[No Abstract] [Full Text] [Related]
32. [Histryl--a new antihistaminic drug].
Bernhardt E
Przegl Dermatol; 1969; 56(4):501-3. PubMed ID: 4390954
[No Abstract] [Full Text] [Related]
33. A trial of dimethothiazine in general practice.
Marshall BY
Practitioner; 1967 Jun; 198(188):834-5. PubMed ID: 4382920
[No Abstract] [Full Text] [Related]
34. [The introduction of 9,9-dioxopromethazine (Prothanon) into the treatment of skin diseases in hospitalized patients].
Nitzschner H
Pharmazie; 1970 Feb; 25(2):111-3. PubMed ID: 4393059
[No Abstract] [Full Text] [Related]
35. [Clinical experience with a new antihistaminic].
Wolfram S
Wien Med Wochenschr; 1967 Sep; 117(38):868-70. PubMed ID: 4385553
[No Abstract] [Full Text] [Related]
36. [A new antihistaminic in the treatment of allergic diseases].
Basomba A; Oehling A
Rev Clin Esp; 1968 Jun; 109(5):417-22. PubMed ID: 4391259
[No Abstract] [Full Text] [Related]
37. [Tavegyl in the treatment of allergic diseases and neurovascular disorders of the nose].
Melik A
Schweiz Rundsch Med Prax; 1970 May; 59(18):676-8. PubMed ID: 4396440
[No Abstract] [Full Text] [Related]
38. Clinical evaluation of antihistamine, HS-592, in seasonal and perennial allergic rhinitis.
Pan A
Ann Allergy; 1970 Feb; 28(2):69-72. PubMed ID: 4403482
[No Abstract] [Full Text] [Related]
39. [Preliminary results of the use of Celestamin in some dermatoses].
Giuliani V
Minerva Dermatol; 1967 Apr; 42(4):149-52. PubMed ID: 4387074
[No Abstract] [Full Text] [Related]
40. [Value of a new antihistaminic in adaptation and tolerance of any contact lenses].
Coustou B
Bull Soc Ophtalmol Fr; 1972; 72(9):945-9. PubMed ID: 4146952
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
